Skip to the main content.

Cell and Gene Blog Series: Part 6 - Future ATMP Manufacturing Paradigms

Cell and Gene Blog Series: Part 6 - Future ATMP Manufacturing Paradigms

Blog 6, the penultimate episode in this series, focuses upon how ATMPs are manufactured along with current trends. In this chapter, Dr Dave Seaward also peers into how equipment and consumables supporting this sector might evolve.

Behind the scenes of 3P innovation's Customer Care team

Behind the scenes of 3P innovation's Customer Care team

This week, I had the chance to sit down with Paul Beard, Operations Director at 3P innovation, to explore what truly distinguishes our Customer Care...

Read More
Filling syringes with spray-dried powders - the how, the why and the benefits.

Filling syringes with spray-dried powders - the how, the why and the benefits.

For many therapy developers, the challenge doesn’t start in manufacturing, it begins much earlier in formulation. Once a promising therapy has...

Read More
What does Annex 1 mean for cryovial filling? Insights from 3P innovation.

What does Annex 1 mean for cryovial filling? Insights from 3P innovation.

The revision of EU GMP Annex 1 has redefined expectations for sterile manufacturing across the life sciences sector and nowhere is this felt more...

Read More